Who Is at Greatest Risk for Emergency Department Visits After a Skin Cancer Diagnosis?

June 27, 2025

DermaSensor Cuts Physicians’ Missed Skin Cancers by Half

June 12, 2025

AI in Action: PanDerm Boosts Diagnostic Accuracy via Multimodal Images

June 10, 2025

ASCO 2025 News: Lifileucel Produces Long-Term Responses and Survival in Advanced Melanoma

June 4, 2025

ASCO News: Avelumab (Bavencio,EMD Serono)-Cetuximab (Erbitux, Lilly) Combo Meets Primary Endpoint in Phase 2 cSCC Trial

June 2, 2025

ASCO News: Cemiplimab (Libtayo, Regeneron Pharmaceuticals, Inc.) Performs Well in High-risk cSCC in the Adjuvant Setting

June 2, 2025

ASCO 2025: DecisionDx-Melanoma Provides More Precise Mortality Risk Predictions for Melanoma Patients

May 30, 2025

Edible Sunscreens: What Your Patients Need to Know Now

May 30, 2025

Novel Biomarker Linked to cSCC Metastasis

May 29, 2025

Milestone Alert: More Than 300,000 Patients With Suspicious Lesions Have Been Assessed Using Nevisense

May 27, 2025

AI Medical Technology’s Dermalyser Earns CE Mark in Europe

May 27, 2025

New Nanoencapsulated CBD Cream Protects Against UVA-Induced Skin Damage

May 23, 2025